New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Pfizer Inc.

PFE

Healthcare Drug Manufacturers General

Pfizer Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.6 billion, down 1.65% from fiscal 2024.

Revenue
−0.43%
EPS
−9.68%
Free cash flow
+20.0%
Total debt
+1.55%

Quarter to September 2026, against a year earlier

27.68 0.11 +0.40%
Market cap
$158.2B
P/E
38.8×
Fwd P/E FY26e
18.7×
Dividend yield
6.24%
F-score
6/9
ROIC
6.19%
Net debt / EBITDA
2.5×
Payout ratio
2.5×

Pfizer Inc. (PFE) EV/FCF

Alert me on EV/FCF

As of Nov 19, 2026, Pfizer Inc. (PFE) trades at a EV/FCF of 18.7×. Over the past ten years it has ranged from 8.4× (October 2021) to 59.9× (July 2024); the current reading is higher than 56% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 23.3× 8.38%
FY2024 21.5× (62.19%)
FY2023 56.8× 377.05%
FY2022 11.9× 2.42%
FY2021 11.6× (42.98%)
FY2020 20.4× (19.27%)
FY2019 25.3× 26.50%
FY2018 20.0× 22.69%
FY2017 16.3× 4.34%
FY2016 15.6× 0.52%

Quarterly newest first

Period EV/FCF Change
Sep 2026 19.2× 3.63%
Jun 2026 18.5× (23.81%)
Mar 2026 24.3× 4.44%
Dec 2025 23.3× 16.40%
43 more quarters

Against its own ten years

Low 8.4× High 59.9×
Ten-year median 17.3×
Current reading's percentile 52

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on PFE